DK1121145T3 - Insulinpræparater til indgivelse via lungerne, som indeholder mentol - Google Patents

Insulinpræparater til indgivelse via lungerne, som indeholder mentol

Info

Publication number
DK1121145T3
DK1121145T3 DK99948726T DK99948726T DK1121145T3 DK 1121145 T3 DK1121145 T3 DK 1121145T3 DK 99948726 T DK99948726 T DK 99948726T DK 99948726 T DK99948726 T DK 99948726T DK 1121145 T3 DK1121145 T3 DK 1121145T3
Authority
DK
Denmark
Prior art keywords
insulin
formulation
administration via
insulin preparations
menthol
Prior art date
Application number
DK99948726T
Other languages
Danish (da)
English (en)
Inventor
Svend Havelund
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of DK1121145T3 publication Critical patent/DK1121145T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK99948726T 1998-10-16 1999-10-15 Insulinpræparater til indgivelse via lungerne, som indeholder mentol DK1121145T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199801326 1998-10-16
PCT/DK1999/000557 WO2000023099A1 (en) 1998-10-16 1999-10-15 Insulin preparations for pulmonary delivery containing menthol

Publications (1)

Publication Number Publication Date
DK1121145T3 true DK1121145T3 (da) 2002-08-12

Family

ID=8103609

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99948726T DK1121145T3 (da) 1998-10-16 1999-10-15 Insulinpræparater til indgivelse via lungerne, som indeholder mentol

Country Status (20)

Country Link
EP (1) EP1121145B1 (pt)
JP (1) JP2002527488A (pt)
KR (1) KR20010080132A (pt)
CN (1) CN1323220A (pt)
AT (1) ATE216258T1 (pt)
AU (1) AU758108B2 (pt)
BR (1) BR9914568A (pt)
CA (1) CA2346884A1 (pt)
CZ (1) CZ20011133A3 (pt)
DE (1) DE69901314T2 (pt)
DK (1) DK1121145T3 (pt)
ES (1) ES2177324T3 (pt)
HU (1) HUP0103606A3 (pt)
IL (1) IL142002A0 (pt)
NO (1) NO20011841L (pt)
PL (1) PL347171A1 (pt)
PT (1) PT1121145E (pt)
UA (1) UA67798C2 (pt)
WO (1) WO2000023099A1 (pt)
ZA (1) ZA200102068B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7089053B1 (en) 1999-10-14 2006-08-08 Pola Chemical Industries Inc Compositions for drug administration by electroporation
EP1222931B1 (en) * 1999-10-15 2006-06-07 Pola Chemical Industries Inc. Percutaneous absorption promoters for electroporation
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
MX349717B (es) 2008-10-17 2017-08-09 Sanofi Aventis Deutschland Combinación de una insulina y un agonista de glp-1.
HUE037735T2 (hu) 2009-11-13 2018-09-28 Sanofi Aventis Deutschland DesPro36exendin-4(1-39)-Lys6-NH2-t és metionint tartalmazó gyógyszerkészítmény
TR201809460T4 (tr) 2009-11-13 2018-07-23 Sanofi Aventis Deutschland Bir GLP- 1-agonisti, bir insülin ve metiyonin içeren farmasötik bileşim.
SI2611458T1 (sl) 2010-08-30 2017-01-31 Sanofi-Aventis Deutschland Gmbh Uporaba AVE0010 za izdelavo zdravila za zdravljenje sladkorne bolezni tipa 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
RU2650616C2 (ru) 2011-08-29 2018-04-16 Санофи-Авентис Дойчланд Гмбх Фармацевтическая комбинация для применения при гликемическом контроле у пациентов с сахарным диабетом 2 типа
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
SI3229828T1 (sl) 2014-12-12 2023-06-30 Sanofi-Aventis Deutschland Gmbh Formulacija s fiksnim razmerjem inzulin glargin/liksisenatid
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506203C1 (en) * 1993-06-24 2001-02-06 Astra Ab Systemic administration of a therapeutic preparation
US5474978A (en) * 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
US5504188A (en) * 1994-06-16 1996-04-02 Eli Lilly And Company Preparation of stable zinc insulin analog crystals
US5635161A (en) * 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
ATE369146T1 (de) * 1996-06-20 2007-08-15 Novo Nordisk As Insulinpreparation mit mannitol
JP2001518916A (ja) * 1997-03-20 2001-10-16 ノボ ノルディスク アクティーゼルスカブ 結晶インスリンを含有する肺投与のための治療用粉末調合物

Also Published As

Publication number Publication date
CA2346884A1 (en) 2000-04-27
DE69901314T2 (de) 2002-11-21
WO2000023099A1 (en) 2000-04-27
NO20011841L (no) 2001-06-15
CZ20011133A3 (cs) 2001-08-15
ZA200102068B (en) 2001-10-12
AU6189099A (en) 2000-05-08
KR20010080132A (ko) 2001-08-22
EP1121145A1 (en) 2001-08-08
EP1121145B1 (en) 2002-04-17
NO20011841D0 (no) 2001-04-10
AU758108B2 (en) 2003-03-13
HUP0103606A2 (hu) 2002-02-28
UA67798C2 (uk) 2004-07-15
IL142002A0 (en) 2002-03-10
PL347171A1 (en) 2002-03-25
HUP0103606A3 (en) 2002-05-28
PT1121145E (pt) 2002-09-30
JP2002527488A (ja) 2002-08-27
DE69901314D1 (de) 2002-05-23
BR9914568A (pt) 2001-07-03
ES2177324T3 (es) 2002-12-01
ATE216258T1 (de) 2002-05-15
CN1323220A (zh) 2001-11-21

Similar Documents

Publication Publication Date Title
DK1121145T3 (da) Insulinpræparater til indgivelse via lungerne, som indeholder mentol
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
ATE277630T1 (de) Stabile konzentrierte insulin präparationen zur pulmonaren verabreichung
GEP20043258B (en) Systems and Methods for Aerosolizing Pharmaceutical Formulations
YU56600A (sh) Uređaj za raznošenje aktivnog agensa u pluća pacijenta
PT1309503E (pt) Dispositivo medico de pulverizacao
CO4410203A1 (es) Formulaciones de analogos de insulina
HRP20000867B1 (en) Pharmaceutical formulations for aerosols with two or more active substances
BR9917089A (pt) Composições e métodos para distribuição mucosal
RU94040387A (ru) Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака
MY129112A (en) Flow resistance modulated aerosolized active agent delivery
DK1091729T3 (da) Mikropartikelformulering til inhalation
DK0458894T3 (da) Lipidexcipiens til nasal afgivelse og topisk påføring
TR200100144T2 (tr) Farmasötik aerosol formülasyonu
YU54499A (sh) Farmaceutski preparat za primenu na mukozu
HK1020866A1 (en) Pharmaceutical injectable solutions containing paracetamol and combinations of paracetamol with other active substances
IL140848A (en) Pharmaceutical compositions containing phenylacetylglutamine, phenylacetylisoglutamine and/or phenylacetate
ATE253928T1 (de) Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung enthaltend desmopressin
BRPI0014878B8 (pt) composição farmacêutica contendo ciclosonida para aplicação à mucosa
DK1673074T3 (da) Flydende præparat, indeholdende tobramycin
TR199900523T2 (xx) Vir�s k�kenli hastal�klar�n tedavisi i�in farmas�tik bile�imler.
SE9904132D0 (sv) Pharmaceutical composition for treatment of diarrhea
UA31873A (uk) Спосіб вакцино-профілактики птиці